Onychomycosis (Tinea Unguium) Drug Market Report

Global Onychomycosis (Tinea Unguium) Drug Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 23, 2022
  • PAGES：201
  • REPORT CODE：GMM766104
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Onychomycosis (Tinea Unguium) Drug market report explains the definition, types, applications, major countries, and major players of the Onychomycosis (Tinea Unguium) Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Novartis

    • Letai

    • GSK

    • Kaken Pharmaceutical

    • Valeant Pharma

    • Johnson & Johnson

    • Qilu Pharmaceutical

    • Xiuzheng Pharmaceutical

    • Pfizer

    • Galderma

    By Type:

    • Oral Type

    • External Use Type

    By End-User:

    • Age under 18

    • Age 18-50

    • Age above 50

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Onychomycosis (Tinea Unguium) Drug Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Onychomycosis (Tinea Unguium) Drug Outlook to 2028- Original Forecasts

    • 2.2 Onychomycosis (Tinea Unguium) Drug Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Onychomycosis (Tinea Unguium) Drug Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Onychomycosis (Tinea Unguium) Drug Market- Recent Developments

    • 6.1 Onychomycosis (Tinea Unguium) Drug Market News and Developments

    • 6.2 Onychomycosis (Tinea Unguium) Drug Market Deals Landscape

    7 Onychomycosis (Tinea Unguium) Drug Raw Materials and Cost Structure Analysis

    • 7.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials

    • 7.2 Onychomycosis (Tinea Unguium) Drug Price Trend of Key Raw Materials

    • 7.3 Onychomycosis (Tinea Unguium) Drug Key Suppliers of Raw Materials

    • 7.4 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate of Raw Materials

    • 7.5 Onychomycosis (Tinea Unguium) Drug Cost Structure Analysis

      • 7.5.1 Onychomycosis (Tinea Unguium) Drug Raw Materials Analysis

      • 7.5.2 Onychomycosis (Tinea Unguium) Drug Labor Cost Analysis

      • 7.5.3 Onychomycosis (Tinea Unguium) Drug Manufacturing Expenses Analysis

    8 Global Onychomycosis (Tinea Unguium) Drug Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Onychomycosis (Tinea Unguium) Drug Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Onychomycosis (Tinea Unguium) Drug Export by Region (Top 10 Countries) (2017-2028)

    9 Global Onychomycosis (Tinea Unguium) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Type Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global External Use Type Consumption and Growth Rate (2017-2022)

    • 9.2 Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Age under 18 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Age 18-50 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Age above 50 Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Onychomycosis (Tinea Unguium) Drug Market Analysis and Outlook till 2022

    • 10.1 Global Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.2.2 Canada Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.2.3 Mexico Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.2 UK Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.3 Spain Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.4 Belgium Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.5 France Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.6 Italy Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.7 Denmark Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.8 Finland Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.9 Norway Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.10 Sweden Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.11 Poland Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.12 Russia Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.3.13 Turkey Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.2 Japan Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.3 India Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.4 South Korea Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.5 Pakistan Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.6 Bangladesh Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.7 Indonesia Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.8 Thailand Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.9 Singapore Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.10 Malaysia Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.11 Philippines Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.4.12 Vietnam Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.2 Colombia Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.3 Chile Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.4 Argentina Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.5 Venezuela Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.6 Peru Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.7 Puerto Rico Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.5.8 Ecuador Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.6.2 Kuwait Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.6.3 Oman Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.6.4 Qatar Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.7.2 South Africa Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.7.3 Egypt Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.7.4 Algeria Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

      • 10.8.2 New Zealand Onychomycosis (Tinea Unguium) Drug Consumption (2017-2022)

    11 Global Onychomycosis (Tinea Unguium) Drug Competitive Analysis

    • 11.1 Novartis

      • 11.1.1 Novartis Company Details

      • 11.1.2 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Novartis Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.1.4 Novartis Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Letai

      • 11.2.1 Letai Company Details

      • 11.2.2 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Letai Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.2.4 Letai Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GSK

      • 11.3.1 GSK Company Details

      • 11.3.2 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GSK Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.3.4 GSK Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Kaken Pharmaceutical

      • 11.4.1 Kaken Pharmaceutical Company Details

      • 11.4.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.4.4 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Valeant Pharma

      • 11.5.1 Valeant Pharma Company Details

      • 11.5.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.5.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Johnson & Johnson

      • 11.6.1 Johnson & Johnson Company Details

      • 11.6.2 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.6.4 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Qilu Pharmaceutical

      • 11.7.1 Qilu Pharmaceutical Company Details

      • 11.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.7.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Xiuzheng Pharmaceutical

      • 11.8.1 Xiuzheng Pharmaceutical Company Details

      • 11.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Details

      • 11.9.2 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Pfizer Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.9.4 Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Galderma

      • 11.10.1 Galderma Company Details

      • 11.10.2 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Galderma Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

      • 11.10.4 Galderma Onychomycosis (Tinea Unguium) Drug Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Onychomycosis (Tinea Unguium) Drug Market Outlook by Types and Applications to 2028

    • 12.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Type Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global External Use Type Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Age under 18 Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Age 18-50 Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Age above 50 Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Onychomycosis (Tinea Unguium) Drug Market Analysis and Outlook to 2028

    • 13.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.2.2 Canada Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.2 UK Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.3 Spain Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.5 France Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.6 Italy Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.8 Finland Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.9 Norway Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.11 Poland Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.12 Russia Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.2 Japan Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.3 India Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.3 Chile Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.6 Peru Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.6.3 Oman Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Onychomycosis (Tinea Unguium) Drug

    • Figure of Onychomycosis (Tinea Unguium) Drug Picture

    • Table Global Onychomycosis (Tinea Unguium) Drug Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Type Consumption and Growth Rate (2017-2022)

    • Figure Global External Use Type Consumption and Growth Rate (2017-2022)

    • Figure Global Age under 18 Consumption and Growth Rate (2017-2022)

    • Figure Global Age 18-50 Consumption and Growth Rate (2017-2022)

    • Figure Global Age above 50 Consumption and Growth Rate (2017-2022)

    • Figure Global Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Table North America Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure United States Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Canada Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Mexico Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure Germany Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure UK Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Spain Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Belgium Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure France Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Italy Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Denmark Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Finland Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Norway Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Sweden Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Poland Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Russia Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Turkey Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table APAC Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure China Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Thailand Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Singapore Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Philippines Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table South America Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure Brazil Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Colombia Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Chile Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Argentina Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Peru Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table GCC Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure Bahrain Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Oman Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Qatar Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table Africa Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure Nigeria Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Africa Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Egypt Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure Algeria Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table Oceania Onychomycosis (Tinea Unguium) Drug Consumption by Country (2017-2022)

    • Figure Australia Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate (2017-2022)

    • Table Novartis Company Details

    • Table Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Novartis Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Letai Company Details

    • Table Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Letai Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Letai Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table GSK Company Details

    • Table GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table GSK Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Kaken Pharmaceutical Company Details

    • Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Valeant Pharma Company Details

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Qilu Pharmaceutical Company Details

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Xiuzheng Pharmaceutical Company Details

    • Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Table Galderma Company Details

    • Table Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma Onychomycosis (Tinea Unguium) Drug Main Business and Markets Served

    • Table Galderma Onychomycosis (Tinea Unguium) Drug Product Portfolio

    • Figure Global Oral Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Use Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age under 18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age 18-50 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age above 50 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Table North America Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure Germany Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure Brazil Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Country (2022-2028)

    • Figure Australia Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Onychomycosis (Tinea Unguium) Drug Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US